Scoop has an Ethical Paywall
Blis Technologies shares fall 11% after price query
Blis Technologies shares fall 11% after price query
By Paul McBeth
July 8 (BusinessDesk) - Blis Technologies shares dropped 11 percent after the biotechnology firm was quizzed over a spike in the share price by the stock market operator.
The shares fell 0.5 cents to 4.2 cents after the Dunedin-based company got a price inquiry from NZX Regulation over a 42 percent gain in the stock since June 30. Blis said it had nothing to disclose under the stock market's listing rules on continuous disclosure. The stock is still trading above the 3.3 cents price it closed at on June 30.
In May, the company reported a smaller loss of $816,000 in the year ended March 31 on revenue of $5.6 million, and said it was on track to deliver its first annual profit in 2017. Blis listed 15 years ago and has accumulated losses of $33.3 million.
Blis was set up to commercialise probiotic bacteria for use in consumer products for oral health, colds and flu and is focused on managing growth and continuing its strategy of securing regulatory approvals market by market.
(BusinessDesk)
Business Canterbury: Urges Council To Cut Costs, Not Ambition For City
Wellington Airport: On Track For Net Zero Emissions By 2028
Landcare Research: ANZAC Gall Fly Release Promises Natural Solution To Weed Threat
NZ Anti-Vivisection Society: Auckland Rat Lovers Unite!
University of Canterbury: $1.35 Million Grant To Study Lion-like Jumping Spiders
Federated Farmers: Government Ends War On Farming
